Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: J Allergy Clin Immunol. 2018 Dec 5;143(5):1760–1768. doi: 10.1016/j.jaci.2018.10.060

Table III –

Treatment Step Overview by Clinical Trial for Participants with Acceptable Adherence

Control Level ACE ICATA PROSE
1 First visit at control level 1
Continue same controller regimen

Consecutive visits at control level 1
Decrease controller regimen by 1 step.
Decrease controller regimen by 1 step.
2 Increase controller regimen by 1 step
3 Increase controller regimen by 2 steps No systemic corticosteroids since the last visit
Increase controller regimen by 1 step**

≥1 course(s) of systemic corticosteroids since the last visit
Increase controller regimen by 2 steps**
4 Increase controller regimen by 3 steps** Increase controller regimen by 2 steps**
*

Full details in study protocols posted included as supplemental material.

**

Treatment step includes prednisone at the physician’s discretion in combination with a treatment increase